0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development

      correction

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Contributors
          catherine.mease@fda.hhs.gov
          Journal
          Orphanet J Rare Dis
          Orphanet J Rare Dis
          Orphanet Journal of Rare Diseases
          BioMed Central (London )
          1750-1172
          21 March 2024
          21 March 2024
          2024
          : 19
          : 131
          Affiliations
          [1 ]GRID grid.417587.8, ISNI 0000 0001 2243 3366, Office of Orphan Products Development, Office of the Commissioner, , US Food and Drug Administration, ; 10903 New Hampshire Ave, 20993 Silver Spring, MD USA
          [2 ]GRID grid.417587.8, ISNI 0000 0001 2243 3366, Office of Pediatric Therapeutics, Office of the Commissioner, , US Food and Drug Administration, ; 10903 New Hampshire Ave, 20993 Silver Spring, MD USA
          [3 ]Office of Therapeutic Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, ( https://ror.org/02nr3fr97) 10903 New Hampshire Ave, 20993 Silver Spring, MD USA
          Author information
          http://orcid.org/0009-0005-0156-198X
          Article
          3136
          10.1186/s13023-024-03136-7
          10958872
          38515155
          9cf5a3a5-69a7-45da-ba38-397c165c79c7
          © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2024

          Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

          History
          Categories
          Correction
          Custom metadata
          © Institut National de la Santé et de la Recherche Médicale (INSERM) 2024

          Infectious disease & Microbiology
          Infectious disease & Microbiology

          Comments

          Comment on this article